直真科技(003007.SZ)聯合體預中標算力項目
格隆匯10月25日丨直真科技(003007.SZ)公佈,近日,《中國招標投標公共服務平台》《河南省電子招標投標公共服務平台》《鄭州航空港經濟綜合實驗區(鄭州新鄭綜合保税區)公共資源交易中心網站》等平台發佈了《鄭州航空港經濟綜合實驗區大數據產業園大數據處理中心項目算力集羣部分建設、維護、運營一體化一標段中標候選人公示》,公司與河南智雲數據信息技術股份有限公司組成的聯合體為該項目中標候選人之一。
據悉,本項目是鄭州航空港經濟綜合實驗區大數據產業園大數據處理中心項目算力集羣部分建設、維護、運營一體化項目,符合公司算力網絡業務方向的總體戰略佈局,有利於充分發揮公司算力調度、算力服務平台建設等方面的優勢,完善相關業務佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.